Experienced in HNRNPH2-Related Disorder

Dr. Elizabeth M. Berry-Kravis

Pediatric Neurology | Pediatrics | Psychiatry
Rush
Rush University Medical Group
1725 W Harrison St, 
Chicago, IL 
Accepting New Patients
Offers Telehealth

Experienced in HNRNPH2-Related Disorder
Rush
Rush University Medical Group
1725 W Harrison St, 
Chicago, IL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Elizabeth Berry-Kravis is a Pediatric Neurologist and a Pediatrics provider in Chicago, Illinois. Dr. Berry-Kravis is rated as an Experienced provider by MediFind in the treatment of HNRNPH2-Related Disorder. Her top areas of expertise are Fragile X Syndrome, Niemann-Pick Disease, Autism Spectrum Disorder, and Rett Syndrome. Dr. Berry-Kravis is currently accepting new patients.

Her clinical research consists of co-authoring 277 peer reviewed articles and participating in 10 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Pediatric Neurology
Pediatrics
Psychiatry
Licenses
Pediatrics in IL
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Dean Health
  • EPO
  • HMO
  • POS
  • PPO
Group Health Cooperative
  • HMO
  • POS
  • PPO
Health Alliance
  • EPO
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Icare Independent Care Health Plan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
MercyCare
  • EPO
  • HMO
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Northern Plains Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE PDP
SCAN Health Plan
  • INSURANCE PLAN
  • MEDICARE MAPD
SelectHealth
  • HMO
  • POS
Spectrum Priority Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 19 Less Insurance Carriers -

Locations

RUSH UNIVERSITY MEDICAL GROUP
1725 W Harrison St, Chicago, IL 60612
Call: 847-608-7517
Other Locations
RUSH UNIVERSITY MEDICAL GROUP
1800 Mcdonough Rd, Suite 203, Hoffman Estates, IL 60192
Call: 847-608-7517
RUSH UNIVERSITY MEDICAL GROUP
1700 W Van Buren St, Chicago, IL 60612
Call: 312-563-2875

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


10 Clinical Trials

Cerliponase Alfa Observational Study
Cerliponase Alfa Observational Study
Enrollment Status: Active_not_recruiting
Publish Date: May 25, 2025
Intervention Type: Drug, Device
A Randomized, Double-Blind, Placebo-Controlled, Multiple-Center, Efficacy and Safety Study of ZYN002 Administered as a Transdermal Gel to Children, Adolescents and Young Adults With Fragile X Syndrome - RECONNECT
A Randomized, Double-Blind, Placebo-Controlled, Multiple-Center, Efficacy and Safety Study of ZYN002 Administered as a Transdermal Gel to Children, Adolescents and Young Adults With Fragile X Syndrome - RECONNECT
Enrollment Status: Active_not_recruiting
Publish Date: May 25, 2025
Intervention Type: Drug
Study Drug: ZYN002
Study Phase: Phase 3
Mapping the Phenotype in Adults With Phelan-McDermid Syndrome
Mapping the Phenotype in Adults With Phelan-McDermid Syndrome
Enrollment Status: Completed
Publish Date: February 18, 2025
Intervention Type: Other
Mapping the Genotype, Phenotype, and Natural History of Phelan-McDermid Syndrome
Mapping the Genotype, Phenotype, and Natural History of Phelan-McDermid Syndrome
Enrollment Status: Active_not_recruiting
Publish Date: February 17, 2025
A Randomized, Double-blind, Placebo-controlled, 2-period Crossover Study of BPN14770 in Adult Males With Fragile X Syndrome
A Randomized, Double-blind, Placebo-controlled, 2-period Crossover Study of BPN14770 in Adult Males With Fragile X Syndrome
Enrollment Status: Completed
Publish Date: December 19, 2024
Intervention Type: Drug
Study Phase: Phase 2
A Randomized, Double-blind, Placebo-controlled, Cross-over Study to Assess the Safety, Tolerability and Efficacy of Oral Ketamine for Patients With Rett Syndrome
A Randomized, Double-blind, Placebo-controlled, Cross-over Study to Assess the Safety, Tolerability and Efficacy of Oral Ketamine for Patients With Rett Syndrome
Enrollment Status: Completed
Publish Date: May 28, 2024
Intervention Type: Drug
Study Drug: Ketamine
Study Phase: Phase 2
A Phase 2, Placebo-controlled, Adaptive Design Study to Explore the Safety and Efficacy of Sulindac (HLX-0201) and Gaboxadol (HLX-0206) and Possible Other Treatments in Adolescent and Adult Males With Fragile X Syndrome (FXS)
A Phase 2, Placebo-controlled, Adaptive Design Study to Explore the Safety and Efficacy of Sulindac (HLX-0201) and Gaboxadol (HLX-0206) and Possible Other Treatments in Adolescent and Adult Males With Fragile X Syndrome (FXS)
Enrollment Status: Withdrawn
Publish Date: December 08, 2022
Intervention Type: Drug
Study Drugs: Sulindac, Gaboxadol
Study Phase: Phase 2
Rett Syndrome, MECP2 Duplication Disorder, and Rett- Related Disorders Natural History Protocol
Rett Syndrome, MECP2 Duplication Disorder, and Rett- Related Disorders Natural History Protocol
Enrollment Status: Completed
Publish Date: August 05, 2021
Biobanking of Rett Syndrome and Related Disorders Protocol
Biobanking of Rett Syndrome and Related Disorders Protocol
Enrollment Status: Completed
Publish Date: August 05, 2021
Double-Blind, Placebo-Controlled Proof of Concept Study in Youth With Fragile X Syndrome
Double-Blind, Placebo-Controlled Proof of Concept Study in Youth With Fragile X Syndrome
Enrollment Status: Completed
Publish Date: February 03, 2021
Intervention Type: Drug
Study Phase: Phase 1
View 9 Less Clinical Trials

268 Total Publications

Development of a Goal Attainment Scale (GAS) outcome measure for clinical interventional studies in paediatric autism.
Development of a Goal Attainment Scale (GAS) outcome measure for clinical interventional studies in paediatric autism.
Journal: Autism : the international journal of research and practice
Published: June 25, 2025
View All 268 Publications
Similar Doctors
Distinguished in HNRNPH2-Related Disorder
Dr. Gifty Bhat
Medical Genetics | Pediatrics
Distinguished in HNRNPH2-Related Disorder
Dr. Gifty Bhat
Medical Genetics | Pediatrics
1801 W Taylor St Ste 2e, Ui Health Occ, 
Chicago, IL 
 (1.0 miles away)
312-996-7416
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Gifty Bhat is a Medical Genetics specialist and a Pediatrics provider in Chicago, Illinois. Dr. Bhat is rated as a Distinguished provider by MediFind in the treatment of HNRNPH2-Related Disorder. Her top areas of expertise are Microcephaly, HNRNPH2-Related Disorder, Chromosome 6q Duplication, and Chromosome 8p Deletion. Dr. Bhat is currently accepting new patients.

Advanced in HNRNPH2-Related Disorder
Dr. Tracy S. Gertler
Pediatric Neurology | Neurology
Advanced in HNRNPH2-Related Disorder
Dr. Tracy S. Gertler
Pediatric Neurology | Neurology
225 E Chicago Ave, 
Chicago, IL 
 (3.0 miles away)
312-227-3550
Languages Spoken:
English
See accepted insurances

Tracy Gertler is a Pediatric Neurologist and a Neurologist in Chicago, Illinois. Dr. Gertler is rated as an Advanced provider by MediFind in the treatment of HNRNPH2-Related Disorder. Her top areas of expertise are Seizures, Athetosis, Myoclonic Epilepsy, and Epilepsy in Children.

Advanced in HNRNPH2-Related Disorder
Dr. Kenneth Silver
Pediatrics
Advanced in HNRNPH2-Related Disorder
Dr. Kenneth Silver
Pediatrics
5841 S Maryland Ave Mc 3055, University Of Chicago Hospitals & Clinics, 
Chicago, IL 
 (7.3 miles away)
773-702-6487
Languages Spoken:
English
See accepted insurances

Kenneth Silver is a Pediatrics provider in Chicago, Illinois. Dr. Silver is rated as a Distinguished provider by MediFind in the treatment of HNRNPH2-Related Disorder. His top areas of expertise are Alternating Hemiplegia of Childhood, HNRNPH2-Related Disorder, Microcephaly, and Delayed Growth.

VIEW MORE HNRNPH2-RELATED DISORDER DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Berry-Kravis's expertise for a condition
ConditionClose
  • Elite
  • Autism Spectrum Disorder
    Dr. Berry-Kravis is
    Elite
    . Learn about Autism Spectrum Disorder.
    See more Autism Spectrum Disorder experts
  • Fragile X Syndrome
    Dr. Berry-Kravis is
    Elite
    . Learn about Fragile X Syndrome.
    See more Fragile X Syndrome experts
  • Niemann-Pick Disease
    Dr. Berry-Kravis is
    Elite
    . Learn about Niemann-Pick Disease.
    See more Niemann-Pick Disease experts
  • Distinguished
  • Angelman Syndrome
    Dr. Berry-Kravis is
    Distinguished
    . Learn about Angelman Syndrome.
    See more Angelman Syndrome experts
  • Batten Disease
    Dr. Berry-Kravis is
    Distinguished
    . Learn about Batten Disease.
    See more Batten Disease experts
  • CLN1 Disease
    Dr. Berry-Kravis is
    Distinguished
    . Learn about CLN1 Disease.
    See more CLN1 Disease experts
  • CLN2 Disease
    Dr. Berry-Kravis is
    Distinguished
    . Learn about CLN2 Disease.
    See more CLN2 Disease experts
  • CLN3 Disease
    Dr. Berry-Kravis is
    Distinguished
    . Learn about CLN3 Disease.
    See more CLN3 Disease experts
  • CLN4 Disease
    Dr. Berry-Kravis is
    Distinguished
    . Learn about CLN4 Disease.
    See more CLN4 Disease experts
View All 9 Distinguished Conditions
  • Advanced
  • Antigen-Peptide-Transporter 2 Deficiency
    Dr. Berry-Kravis is
    Advanced
    . Learn about Antigen-Peptide-Transporter 2 Deficiency.
    See more Antigen-Peptide-Transporter 2 Deficiency experts
  • Myoclonic Epilepsy
    Dr. Berry-Kravis is
    Advanced
    . Learn about Myoclonic Epilepsy.
    See more Myoclonic Epilepsy experts
  • Polycystic Lipomembranous Osteodysplasia with Sclerosing Leukoencephalopathy
    Dr. Berry-Kravis is
    Advanced
    . Learn about Polycystic Lipomembranous Osteodysplasia with Sclerosing Leukoencephalopathy.
    See more Polycystic Lipomembranous Osteodysplasia with Sclerosing Leukoencephalopathy experts
  • Seizures
    Dr. Berry-Kravis is
    Advanced
    . Learn about Seizures.
    See more Seizures experts
  • Experienced
  • Absence Seizure
    Dr. Berry-Kravis is
    Experienced
    . Learn about Absence Seizure.
    See more Absence Seizure experts
  • Acid Sphingomyelinase Deficiency (ASMD)
    Dr. Berry-Kravis is
    Experienced
    . Learn about Acid Sphingomyelinase Deficiency (ASMD).
    See more Acid Sphingomyelinase Deficiency (ASMD) experts
  • Amyotonia Congenita
    Dr. Berry-Kravis is
    Experienced
    . Learn about Amyotonia Congenita.
    See more Amyotonia Congenita experts
  • Attention Deficit Hyperactivity Disorder (ADHD)
    Dr. Berry-Kravis is
    Experienced
    . Learn about Attention Deficit Hyperactivity Disorder (ADHD).
    See more Attention Deficit Hyperactivity Disorder (ADHD) experts
  • CACH Syndrome
    Dr. Berry-Kravis is
    Experienced
    . Learn about CACH Syndrome.
    See more CACH Syndrome experts
  • CHARGE Syndrome
    Dr. Berry-Kravis is
    Experienced
    . Learn about CHARGE Syndrome.
    See more CHARGE Syndrome experts
View All 32 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2025 All Rights Reserved